Comparison between Bio Medica Laboratories IPO and Kanishk Aluminium India IPO.
Bio Medica Laboratories IPO is a SME Fixed Price IPO proposed to list at NSE SME while Kanishk Aluminium India IPO is a SME Fixed Price proposed to list at BSE SME.
| Bio Medica Laboratories IPO | Kanishk Aluminium India IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Narnolia Financial Services Ltd. | Sun Capital Advisory Services Pvt.Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Prabhat Financial Services Ltd. | Sunflower Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Bio Medica Laboratories IPO is up to ₹49.80 Cr whereas the issue size of the Kanishk Aluminium India IPO is up to ₹27.74 Cr. The final issue price of Bio Medica Laboratories IPO is ₹139.00 per share and of Kanishk Aluminium India IPO is ₹73.00 per share.
| Bio Medica Laboratories IPO | Kanishk Aluminium India IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹132.00 per share | |
| Issue Price (Upper) | ₹139.00 per share | |
| Issue Price (Final) | ₹139.00 per share | ₹73.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1000 shares | 1600 shares |
| Fresh Issue Size | 32,06,000 shares | 38,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹44.56 Cr | up to ₹27.74 Cr |
| OFS Issue Size | 3,77,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹5.24 Cr | up to ₹0.00 Cr |
| Issue Size Total | 35,83,000 shares | 38,00,000 shares |
| Issue Size Total (Amount) | up to ₹49.80 Cr | up to ₹27.74 Cr |
Bio Medica Laboratories IPO opens on May 21, 2026, while Kanishk Aluminium India IPO opens on Jan 28, 2026. The closing date of Bio Medica Laboratories IPO and Kanishk Aluminium India IPO is May 25, 2026, and Jan 30, 2026, respectively.
| Bio Medica Laboratories IPO | Kanishk Aluminium India IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | May 21, 2026 | Jan 28, 2026 |
| Issue Close | May 25, 2026 | Jan 30, 2026 |
| Basis Of Allotment (Tentative) | May 26, 2026 | Feb 02, 2026 |
| Initiation of Refunds (Tentative) | May 27, 2026 | Feb 03, 2026 |
| Credit of Share (Tentative) | May 27, 2026 | Feb 03, 2026 |
| Listing date (Tentative) | May 29, 2026 | Feb 04, 2026 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Bio Medica Laboratories IPO P/E ratio is 13.03, as compared to Kanishk Aluminium India IPO P/E ratio of 22.66.
| Bio Medica Laboratories IPO | Kanishk Aluminium India IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Standalone)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 96.84 | 99.99 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 70.24 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 13.03 | 22.66 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹174.79 Cr. | ₹98.11 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 99.59 | 20.21 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 48.20 | 14.61 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.02 | 1.37 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹10.67 | ₹3.22 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 99.59 | 20.21 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Bio Medica Laboratories IPO Retail Individual Investors (RII) are offered 17,92,000 shares while in Kanishk Aluminium India IPO retail investors are offered 17,92,000 shares. Qualified Institutional Buyers (QIB) are offered 36,000 shares in Bio Medica Laboratories IPO and 0 shares in Kanishk Aluminium India IPO.
| Bio Medica Laboratories IPO | Kanishk Aluminium India IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 1,89,000 shares | 2,00,000 shares |
| QIB | 36,000 shares | 0 shares |
| NII | 17,55,000 shares | 18,99,200 shares |
| RII | 17,92,000 shares | 19,00,800 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 35,83,000 shares | 38,00,000 shares |
Bio Medica Laboratories IPO subscribed 2.26x in total, whereas Kanishk Aluminium India IPO subscribed 1.04x.
| Bio Medica Laboratories IPO | Kanishk Aluminium India IPO | |
|---|---|---|
| QIB (times) | 15.94x | |
| NII (times) | 1.30x | 0.23x |
| Big NII (times) | 0.86x | |
| Small NII (times) | 2.19x | |
| RII (times) | 2.92x | 1.86x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.26x | 1.04x |
